Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review
Summary & key facts
This paper is a systematic review that looked at clinical research on using psilocybin (the active ingredient in “magic” mushrooms) to treat substance use disorders, focusing on whether it helps and whether it is safe. The abstract or full text was not provided here, so I cannot report the review’s specific results, numbers, or conclusions. If you share the paper text or abstract, I can summarize the actual findings, what they mean for people, and the study limitations.
- The paper is a systematic review, which means the authors collected and evaluated multiple studies on the same question: whether psilocybin helps treat substance use problems and whether it is safe.
- Psilocybin is the psychedelic compound found in certain mushrooms and is being studied as a possible treatment for mental health and addiction problems.
- A systematic review typically looks at study methods, results, and safety reports to judge how strong and consistent the evidence is across studies.
- Because the abstract or main text was not included here, I cannot say what the review actually found about benefits, risks, or how many people or studies were included.
- If you provide the paper’s abstract or a link to the full text, I can describe the review’s actual results, how strong the evidence seems, and any important limitations the authors noted.
Topics
Chemical synthesis and alkaloids Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug StudiesCategories
Clinical Psychology Psychology Social SciencesTags
Hallucinogen Medicine Psilocybin Psychiatry Psychology Psychotherapist Substance useSubstances
PsilocybinConditions & symptoms
Addiction Substance abuse disorder Addiction or harmful habbitsReferencing articles
Ketamine Vs. Psilocybin Therapy: The Difference in Treatment
Ketamine therapies have been FDA-approved in the US for just shy of a decade, and…